Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

371.53
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
340.09
Today|||52-Week Range
543.55
-1.18%
Year-to-Date
Ophthotech Begins Phase II Zimura Study in Stargardt Disease
Jan 17 / Zacks.com - Paid Partner Content
Regeneron, Sanofi Expand Investment in Cemiplimab & Dupilumab
Jan 09 / Zacks.com - Paid Partner Content
Can Biotech Keep Last Year's Momentum Alive in 2018?
Jan 11 / Zacks.com - Paid Partner Content
Stock Market News For Jan 9, 2018
Jan 09 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Celgene to Acquire Impact, J.P. Morgan Healthcare Conference i...
Jan 10 / Zacks.com - Paid Partner Content
FDA Approvals Surge in 2017: Here's a Look at the Numbers
Jan 09 / Zacks.com - Paid Partner Content
AbbVie's Upadacitinib Gains Breakthrough Therapy Designation
Jan 09 / Zacks.com - Paid Partner Content
Momenta Reports Positive Top-Line Data on Antibody M281
Jan 09 / Zacks.com - Paid Partner Content